О себе
Christina Lee Chung, MD, FAAD is a board-certified dermatologist focused on skin of color and transplant dermatology. She is the CEO and co-founder of Hayflick Therapeutics, a development-stage biotech company building topical rapamycin-based longevity therapeutics. She has also held clinical and research roles at Schweiger Dermatology Group and the Drexel Dermatology Center for Transplant Patients, with publications and lectures on dermatology in patients of color.
Области интересов
longevitybiotechdermatologyskin cancertransplant dermatologyaging biologymTOR biologyhealthspanaestheticssports